Stock listing

NASDAQ:SNGX Soligenix, Inc. Stock

Home listing (NASDAQ) of Soligenix, Inc.

Follow Soligenix, Inc. into a list and get an email when it puts out news.

Share price · NASDAQ:SNGX

$0.356 USD -0.013 (-3.6%)

Close on Oct 30, 2026

Past year -76.4% · daily closes, Oct 30, 2025 – Oct 30, 2026, adjusted for splits
Day range
$0.355 – $0.378 USDOct 30, 2026
Volume
69,423 sharesOct 30, 2026
Market cap
$7.75M USDAt the close on Oct 30, 2026 · price × 21.77M shares outstanding
52-week range
$0.280 – $1.700 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
Traded on an average day
$74,111 USDMedian day 132,000 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Soligenix, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:SNGX · Home$0.356 USD-0.013 (-3.6%)69,423$0.378$0.378$0.355$0.369Close on Oct 30, 2026
LSE:0A6I$0.368 USD+0.008 (+2.1%)11,831$0.350$0.375$0.337$0.360Close on Oct 27, 2026

Daily closes

Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:SNGX · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.356-0.013-3.6%$0.378$0.378$0.35569,423
$0.369-0.006-1.5%$0.376$0.378$0.36836,555
$0.375+0.012+3.3%$0.351$0.375$0.35162,279
$0.363+0.013+3.7%$0.350$0.370$0.35074,407
$0.350-0.020-5.4%$0.369$0.371$0.35047,606
$0.370+0.010+2.8%$0.350$0.370$0.340127,000
$0.360+0.010+2.9%$0.370$0.370$0.350131,600
$0.3500.0000.0%$0.340$0.370$0.34069,100
$0.350+0.010+2.9%$0.340$0.360$0.34081,200
$0.340-0.010-2.9%$0.340$0.350$0.34069,700
$0.350-0.010-2.8%$0.360$0.360$0.350217,700
$0.360+0.020+5.9%$0.340$0.360$0.340163,200
$0.340+0.010+3.0%$0.320$0.350$0.320148,200
$0.330-0.020-5.7%$0.350$0.370$0.330267,400
$0.350-0.010-2.8%$0.360$0.370$0.35061,800
$0.360+0.010+2.9%$0.350$0.370$0.350114,500
$0.3500.0000.0%$0.360$0.360$0.350120,200
$0.350-0.010-2.8%$0.360$0.360$0.35062,800
$0.3600.0000.0%$0.360$0.360$0.360185,600
$0.360-0.010-2.7%$0.360$0.370$0.360107,900
$0.370+0.010+2.8%$0.370$0.370$0.360146,500
$0.3600.0000.0%$0.360$0.370$0.36045,300
$0.360-0.010-2.7%$0.370$0.370$0.36090,300
$0.370-0.010-2.6%$0.380$0.380$0.360406,600
$0.3800.0000.0%$0.380$0.380$0.380135,000
$0.380-0.010-2.6%$0.390$0.390$0.38072,700
$0.3900.0000.0%$0.380$0.390$0.380228,600
$0.3900.0000.0%$0.390$0.390$0.380372,700
$0.390+0.020+5.4%$0.390$0.390$0.380529,800
$0.3700.0000.0%$0.380$0.380$0.370341,300
$0.370-0.010-2.6%$0.370$0.390$0.370257,400
$0.380+0.020+5.6%$0.360$0.400$0.360971,500
$0.3600.0000.0%$0.360$0.360$0.360125,800
$0.3600.0000.0%$0.360$0.370$0.360288,300
$0.3600.0000.0%$0.370$0.370$0.36098,400
$0.3600.0000.0%$0.360$0.370$0.360147,200
$0.360-0.010-2.7%$0.360$0.370$0.360124,100
$0.370-0.010-2.6%$0.380$0.390$0.370126,400
$0.3800.0000.0%$0.380$0.390$0.38095,200
$0.3800.0000.0%$0.380$0.380$0.380119,100
$0.3800.0000.0%$0.390$0.390$0.38059,900
$0.3800.0000.0%$0.380$0.390$0.37090,000
$0.3800.0000.0%$0.370$0.390$0.370122,200
$0.3800.0000.0%$0.380$0.390$0.360400,300
$0.3800.0000.0%$0.380$0.390$0.370139,500
$0.3800.0000.0%$0.380$0.390$0.380379,200
$0.380-0.030-7.3%$0.400$0.400$0.380590,900
$0.410+0.010+2.5%$0.410$0.410$0.400218,100
$0.4000.0000.0%$0.410$0.410$0.400311,100
$0.400+0.020+5.3%$0.380$0.420$0.380989,200
$0.3800.0000.0%$0.380$0.390$0.38094,000
$0.380-0.020-5.0%$0.390$0.390$0.380106,500
$0.400+0.020+5.3%$0.380$0.400$0.380133,900
$0.380-0.020-5.0%$0.390$0.390$0.380113,200
$0.400+0.020+5.3%$0.380$0.400$0.380333,500
$0.380-0.010-2.6%$0.390$0.390$0.380135,800
$0.3900.0000.0%$0.380$0.400$0.380127,100
$0.390+0.010+2.6%$0.380$0.390$0.38095,100
$0.380-0.010-2.6%$0.400$0.400$0.380144,700
$0.390+0.010+2.6%$0.380$0.400$0.380131,700
$0.3800.0000.0%$0.380$0.390$0.380132,300
$0.3800.0000.0%$0.390$0.400$0.380164,400
$0.3800.0000.0%$0.380$0.380$0.380249,200
$0.380+0.010+2.7%$0.380$0.390$0.370197,400
$0.370-0.010-2.6%$0.370$0.400$0.360325,200
$0.380+0.020+5.6%$0.370$0.380$0.350248,600
Ticker
NASDAQ:SNGX
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD

What changed lately

Latest news

Soligenix Applying for Vaccine Development Funding for Bundibugyo Ebola Vaccine

Jun 8, 2026

Closed $0.42 (-4.5%) on Jun 8, 2026

Suitability of Vaccine Platform for Bundibugyo Virus, Cause of the Ebola Outbreak in Congo

May 26, 2026

Closed $0.51 (+30.8%) on May 26, 2026

Soligenix Announces Recent Updates and First Quarter 2026 Financial Results

May 8, 2026

Closed $0.29 (-6.5%) on May 8, 2026

Soligenix Announces Interim Results from the Phase 3 FLASH2 Trial Evaluating HyBryte™ in Treatment of Cutaneous T-Cell Lymphoma

Apr 28, 2026

Closed $0.42 (-70.4%) on Apr 28, 2026

Positive Clinical Results from HyBryte™ Comparative Study Evaluating HyBryte™ Against Valchlor® in the Treatment of Cutaneous T-Cell Lymphoma Published in Oncology and Therapy

Apr 2, 2026

Closed $1.14 (-0.9%) on Apr 2, 2026

Soligenix Announces Recent Accomplishments and Year End 2025 Financial Results

Mar 31, 2026

Closed $1.18 (+6.3%) on Mar 31, 2026

Soligenix Receives Orphan Drug Designation from the European Commission for SGX945 for the Treatment of Behçet's Disease

Mar 26, 2026

Closed $1.21 (+0.8%) on Mar 26, 2026

Soligenix (SNGX) HyBryte Data To Be Presented At USCLC Workshop Ahead Of AAD Meeting

Mar 24, 2026

Closed $1.17 (-3.3%) on Mar 24, 2026

HyBryte™ Treatment Results to be Presented at US Cutaneous Lymphoma Consortium Annual Workshop 2026

Mar 23, 2026

Closed $1.21 (+0.8%) on Mar 23, 2026

Soligenix Announces HyBryte™ Clinical Summary Published in "Expert Opinion on Investigational Drugs"

Mar 19, 2026

Closed $1.22 (0.0%) on Mar 19, 2026

All Soligenix, Inc. news

Decks

Soligenix, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
22 in the last 12 months · 191 in all · newest Jun 8, 2026 · oldest 2019
Decks
29 decks · latest Apr 8, 2026

Where Soligenix, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:SNGX · Home listing · This pageNASDAQUnited StatesUSD
BOATS:SNGXBOATSUnited StatesUSD
gettex:DOA0gettexGermanyEUR
LSE:0A6ILSEUnited KingdomUSD
Munich:DOA0MunichGermanyEUR

Log in to ask 6ix AI your own questions about Soligenix, Inc.